GO:0006221 pyrimidine nucleotide biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006221 describes the chemical reactions and pathways that build pyrimidine nucleotides, the building blocks of RNA and DNA.
• The pathway includes both de novo synthesis and salvage routes that convert pyrimidine bases and nucleosides into phosphorylated nucleotides.
• Pyrimidine nucleotide biosynthesis is essential for nucleic acid synthesis, cell proliferation, and mitochondrial function.
• Dysregulation of this pathway is linked to cancer, antiviral drug targeting, and mitochondrial DNA-dependent innate immunity.
• Key enzymes such as CAD, DHODH, UMPS, and CTP synthase are conserved from bacteria to humans and are studied in models like zebrafish and Pseudomonas.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in this pathway.
Description
Pyrimidine nucleotide biosynthetic process (GO:0006221) is the set of biochemical reactions that produce pyrimidine nucleotides, which are essential for RNA and DNA synthesis and for many cellular signaling processes. This pathway supplies the pyrimidine building blocks required for genome replication and transcription, and its activity is tightly coordinated with cell growth and proliferation. Researchers study this process because its enzymes are targets for antiviral and anticancer therapies, and because imbalances in pyrimidine pools can trigger mitochondrial DNA-dependent innate immune responses. The pathway is conserved across species, from bacteria such as Pseudomonas to vertebrates including zebrafish and humans, making it a tractable system for genetic and pharmacological dissection. Understanding GO:0006221 therefore provides insight into fundamental nucleotide metabolism and its roles in health and disease.
pyrimidine nucleotide biosynthetic process At A Glance
| GO ID | GO:0006221 |
|---|---|
| GO term | pyrimidine nucleotide biosynthetic process |
| Ontology | biological_process |
| Synonym | pyrimidine nucleotide anabolism; pyrimidine nucleotide biosynthesis; pyrimidine nucleotide formation; pyrimidine nucleotide synthesis |
| Major function | Synthesis of pyrimidine nucleotides for RNA, DNA, and cofactor production |
| Key enzymes | CAD, DHODH, UMPS, CTP synthase, and salvage enzymes |
| Pathway routes | De novo synthesis and salvage pathways |
| Cellular location | Cytosol and mitochondria (for some steps) |
| Disease relevance | Cancer, antiviral targeting, mitochondrial innate immunity |
What Is GO:0006221?
GO:0006221, pyrimidine nucleotide biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of a pyrimidine nucleotide, a compound consisting of a nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar. In simpler terms, it is the collection of enzymatic steps that build pyrimidine nucleotides from simpler precursors or salvage them from bases and nucleosides.
Why Is pyrimidine nucleotide biosynthetic process Important in Cell Biology?
Pyrimidine nucleotide biosynthetic process is fundamental to cell growth because it provides the nucleotides needed for DNA replication and RNA transcription. Its dysregulation can lead to nucleotide imbalance, which has been shown to trigger mitochondrial DNA-dependent innate immunity and may contribute to inflammatory or metabolic disorders. In cancer, enzymes of this pathway are often upregulated to support rapid proliferation, making them attractive therapeutic targets. Additionally, the pathway is exploited by viruses, and its enzymes are targets for antiviral chemotherapy. Model organisms such as zebrafish and Pseudomonas species have been used to study the genetic control of pyrimidine nucleotide formation, revealing conserved regulatory mechanisms.
• Provides nucleotides for DNA and RNA synthesis, essential for cell division and gene expression.
• Maintains nucleotide pool balance; imbalance can trigger innate immune responses.
• Enzymes like DHODH and CAD are targets for anticancer and antiviral drugs.
• Supports mitochondrial function and mitochondrial DNA maintenance.
• Conserved across species, enabling comparative studies in bacteria and zebrafish.
• Dysregulation is implicated in cancer metabolic reprogramming.
• Salvage pathways are critical in tissues with high nucleotide demand.
• Genetic defects in pyrimidine metabolism can cause rare disorders, studied in model organisms.
• Pathway flux is coordinated with cell cycle and proliferation signals.
• Provides precursors for UDP-sugars and other nucleotide derivatives.
What Happens During pyrimidine nucleotide biosynthetic process?
De novo synthesis of UMP
In simple terms: The cell builds a pyrimidine ring from scratch to make the first nucleotide, UMP.
The de novo pathway begins with the formation of carbamoyl phosphate and its condensation with aspartate to form carbamoyl aspartate, catalyzed by CAD in humans. Subsequent steps lead to orotate, which is converted to UMP by UMP synthase (UMPS). This pathway is regulated by feedback inhibition and is essential for providing the pyrimidine ring for all pyrimidine nucleotides.
Conversion of UMP to other pyrimidine nucleotides
In simple terms: UMP is modified to make other pyrimidine nucleotides like CTP and dTMP.
UMP is phosphorylated to UDP and UTP, and then CTP synthase converts UTP to CTP. Deoxyribonucleotides are produced by ribonucleotide reductase, and dTMP is synthesized from dUMP by thymidylate synthase. These conversions ensure a balanced supply of pyrimidine nucleotides for RNA and DNA synthesis.
Salvage pathways
In simple terms: The cell recycles pyrimidine bases and nucleosides to save energy.
Salvage enzymes such as uridine phosphorylase and uridine kinase convert uracil and uridine to UMP, and thymidine kinase converts thymidine to dTMP. These pathways are particularly important in tissues with high nucleotide turnover, such as the liver and brain. In bacteria like Pseudomonas, salvage and de novo pathways are coordinately regulated to meet cellular demands.
Regulation of pyrimidine nucleotide biosynthesis
In simple terms: The pathway is turned up or down based on how much nucleotide the cell needs.
In humans, CAD is activated by phosphorylation and regulated by MAPK and mTOR signaling, while DHODH is inhibited by feedback from UMP. In Pseudomonas species, pyrimidine nucleotide formation is controlled by environmental factors and genetic regulators. In zebrafish, mutations in pyrimidine metabolism genes cause developmental defects, highlighting the importance of regulation.
Compartmentalization and mitochondrial roles
In simple terms: Some steps occur in different parts of the cell, including mitochondria.
While most de novo synthesis occurs in the cytosol, mitochondrial enzymes are involved in pyrimidine salvage and in maintaining mitochondrial nucleotide pools. Imbalance in pyrimidine nucleotides can lead to mitochondrial DNA release and innate immune activation. This compartmentalization ensures that both nuclear and mitochondrial DNA replication have adequate nucleotide supplies.
Key Genes Involved in GO:0006221 pyrimidine nucleotide biosynthetic process
The following genes and enzymes are central to pyrimidine nucleotide biosynthetic process and are frequently studied in research and drug development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAD | Trifunctional enzyme catalyzing first steps of de novo pyrimidine synthesis | Target for cancer and antiviral research; regulated by mTOR |
| DHODH | Catalyzes dihydroorotate to orotate, a step in de novo synthesis | Target for immunosuppressants and anticancer drugs |
| UMPS | Converts orotate to UMP | Mutations cause orotic aciduria; studied in zebrafish |
| CTPS1 | Converts UTP to CTP | Essential for lymphocyte proliferation; potential cancer target |
| CTPS2 | CTP synthase isoform | Less studied but may compensate for CTPS1 |
| TYMS | Thymidylate synthase, synthesizes dTMP | Target of 5-fluorouracil in cancer |
| RRM1 | Ribonucleotide reductase subunit, produces deoxyribonucleotides | Target for cancer therapy |
| RRM2 | Ribonucleotide reductase subunit | Overexpressed in many cancers |
| UCK2 | Uridine-cytidine kinase, salvage of uridine and cytidine | Potential target in cancer metabolism |
| UPP1 | Uridine phosphorylase, salvage pathway | Involved in nucleotide homeostasis |
| TK1 | Thymidine kinase, salvage of thymidine | Marker of cell proliferation |
| NME1 | Nucleoside diphosphate kinase, balances nucleotide pools | Studied in cancer metastasis |
| NME2 | Nucleoside diphosphate kinase | Regulates nucleotide pools and signaling |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase, links to purine synthesis | Mutations cause disorders; not specific to pyrimidines |
| GART | Purine synthesis enzyme, included for contrast | Not part of pyrimidine pathway |
| PPAT | Purine synthesis enzyme, included for contrast | Not part of pyrimidine pathway |
| ATIC | Purine synthesis enzyme, included for contrast | Not part of pyrimidine pathway |
How Is pyrimidine nucleotide biosynthetic process Regulated?
Pyrimidine nucleotide biosynthetic process is regulated at multiple levels. In humans, CAD is activated by phosphorylation downstream of mTOR and MAPK signaling, linking nucleotide synthesis to growth signals. DHODH is feedback-inhibited by UMP, and CTP synthase is regulated by CTP levels. In bacteria such as Pseudomonas, pyrimidine nucleotide formation is controlled by environmental factors and genetic regulators, as shown in studies of Pseudomonas lemonnieri and Pseudomonas aurantiaca. In zebrafish, mutations in pyrimidine metabolism genes affect development, indicating tight developmental regulation. Additionally, pyrimidine imbalance can trigger mitochondrial DNA-dependent innate immunity, suggesting a link between nucleotide pools and immune signaling.
pyrimidine nucleotide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAD | Cancer proliferation, antiviral target | Knockout in cancer cell lines; overexpression |
| DHODH | Cancer, autoimmune diseases, antiviral | Point mutation to study inhibitor resistance |
| UMPS | Orotic aciduria, developmental defects | Zebrafish knockout; knock-in of patient mutations |
| CTPS1 | Lymphoproliferative disorders, cancer | Knockout in immune cells; overexpression |
| TYMS | Cancer, drug resistance | Point mutation for 5-FU resistance; knockout |
Cancer
Many cancers upregulate pyrimidine nucleotide biosynthesis to support rapid proliferation. Enzymes such as DHODH, CAD, and thymidylate synthase are overexpressed in various tumors and are targets for chemotherapy. Inhibitors of DHODH and other pathway enzymes are being developed as anticancer agents.
Viral infections
Viruses rely on host pyrimidine nucleotide biosynthesis for replication. Antiviral drugs often target enzymes like DHODH or CTP synthase to deplete nucleotide pools and inhibit viral replication.
Mitochondrial dysfunction and innate immunity
Imbalance in pyrimidine nucleotides can cause mitochondrial DNA release and activate innate immune responses, linking nucleotide metabolism to inflammatory diseases.
Inherited disorders
Mutations in genes such as UMPS cause orotic aciduria, a rare metabolic disorder. Zebrafish models have been used to study developmental defects caused by pyrimidine metabolism mutations.
From pyrimidine nucleotide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CAD required for cancer cell proliferation? | CRISPR knockout of CAD in cancer cell lines |
| Does a specific DHODH mutation confer drug resistance? | Point mutation knock-in of DHODH in cell lines |
| What is the effect of UMPS deficiency on development? | Zebrafish knockout or knock-in of patient mutations |
| Can overexpression of CTPS1 drive lymphocyte proliferation? | Overexpression of CTPS1 in lymphoid cell lines |
| Where is DHODH localized in cells? | Tagged knock-in of DHODH with fluorescent protein |
| What genes regulate pyrimidine biosynthesis in Pseudomonas? | CRISPR interference or knockout in Pseudomonas species |
How to Study the pyrimidine nucleotide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Identify genes required for pyrimidine biosynthesis in cancer cells |
| Metabolomics (LC-MS) | Levels of pyrimidine nucleotides | Measure changes after drug treatment or gene knockout |
| Isotope tracing | Flux through de novo and salvage pathways | Quantify pathway activity in cells |
| RNA-seq | Expression of pathway genes | Compare transcriptomes across conditions |
| Proteomics | Protein abundance and modifications | Study regulation of enzymes like CAD |
| Fluorescence microscopy | Subcellular localization | Visualize tagged enzymes in live cells |
| Zebrafish models | Developmental phenotypes | Study mutations in pyrimidine metabolism genes |
| Bacterial genetics | Growth and regulation | Dissect pathway control in Pseudomonas species |
Genetic screens and CRISPR libraries
CRISPR knockout libraries can identify genes required for pyrimidine nucleotide biosynthesis and uncover synthetic lethal interactions with pathway inhibitors. Pooled screens in cancer cell lines have revealed dependencies on CAD, DHODH, and other enzymes.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can measure pyrimidine nucleotide levels and isotope tracing can quantify flux through de novo and salvage pathways. These methods are used to assess the impact of genetic perturbations or drug treatment.
RNA-seq and proteomics
Transcriptomic and proteomic profiling can reveal changes in expression of pyrimidine biosynthesis genes under different conditions, such as proliferation or immune activation.
Imaging and subcellular localization
Fluorescence microscopy of tagged enzymes can determine subcellular localization and dynamics of pathway components, including mitochondrial association.
How CRISPR Can Be Used to Study GO:0006221 pyrimidine nucleotide biosynthetic process
Knockout
CRISPR knockout of genes such as CAD, DHODH, or UMPS can reveal their essentiality for cell proliferation and survival. Knockout cell lines are used to study pathway dependencies and resistance mechanisms.
Point Mutation
Point mutations can be introduced to model drug-resistant variants or patient-derived mutations in enzymes like DHODH or UMPS. These models help test inhibitor specificity and understand structure-function relationships.
Knock-in
Knock-in of tagged or reporter versions of pathway enzymes allows tracking of protein localization and dynamics. Knock-in of patient mutations in zebrafish or human cells can model inherited disorders.
Overexpression
Overexpression of genes like CTPS1 or CAD can drive increased nucleotide synthesis and proliferation, useful for studying oncogenic potential and pathway regulation.
How EDITGENE Supports pyrimidine nucleotide biosynthetic process Research
Researchers studying pyrimidine nucleotide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for pyrimidine nucleotide biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PRPS1 Knockout HEK293 Cell Line | EDJ-KQ2295 | Human | 5631 | Details Get a Quote |
| SLC4A7 Knockout HEK293 Cell Line | EDJ-KQ6609 | Human | 9497 | Details Get a Quote |
| CTPS2 Knockout HEK293 Cell Line | EDJ-KQ13050 | Human | 56474 | Details Get a Quote |
| PRPS1 Knockout HCT 116 Cell Line | EDJ-KQ21331 | Human | 5631 | Details Get a Quote |
| PRPS1 Knockout A-549 Cell Line | EDJ-KQ22659 | Human | 5631 | Details Get a Quote |
| PRPS1 Knockout HeLa Cell Line | EDJ-KQ22661 | Human | 5631 | Details Get a Quote |
| SLC4A7 Knockout A-549 Cell Line | EDJ-KQ30844 | Human | 9497 | Details Get a Quote |
| SLC4A7 Knockout HCT 116 Cell Line | EDJ-KQ30845 | Human | 9497 | Details Get a Quote |
| SLC4A7 Knockout HeLa Cell Line | EDJ-KQ30846 | Human | 9497 | Details Get a Quote |
| CTPS2 Knockout A-549 Cell Line | EDJ-KQ42322 | Human | 56474 | Details Get a Quote |
| CTPS2 Knockout HCT 116 Cell Line | EDJ-KQ42323 | Human | 56474 | Details Get a Quote |
| CTPS2 Knockout HeLa Cell Line | EDJ-KQ42324 | Human | 56474 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About pyrimidine nucleotide biosynthetic process
What is pyrimidine nucleotide biosynthetic process?
It is the set of biochemical reactions that build pyrimidine nucleotides, the building blocks of RNA and DNA, defined by GO:0006221.
What genes are involved in pyrimidine nucleotide biosynthetic process?
Key genes include CAD, DHODH, UMPS, CTPS1, TYMS, and RRM1/RRM2, among others.
Why is pyrimidine nucleotide biosynthesis important for cancer?
Cancer cells often upregulate this pathway to support rapid proliferation, making its enzymes targets for anticancer drugs.
How is pyrimidine nucleotide biosynthesis regulated?
It is regulated by feedback inhibition, phosphorylation of CAD via mTOR/MAPK, and developmental signals.
What diseases are linked to pyrimidine nucleotide biosynthesis defects?
Defects can cause orotic aciduria, developmental disorders, and may contribute to mitochondrial innate immune activation.
What model organisms are used to study pyrimidine nucleotide biosynthesis?
Zebrafish and Pseudomonas species are used to study genetic control and developmental effects.
How can CRISPR be used to study pyrimidine nucleotide biosynthetic process?
CRISPR knockout, point mutation, knock-in, and overexpression can test gene function and drug response in this pathway.
What methods measure pyrimidine nucleotide levels?
Metabolomics, isotope tracing, and RNA-seq are commonly used to measure pathway activity and gene expression.
Is pyrimidine nucleotide biosynthesis a target for antiviral drugs?
Yes, enzymes like DHODH are targeted by antiviral compounds to deplete nucleotide pools and inhibit viral replication.
What is the role of mitochondria in pyrimidine nucleotide biosynthesis?
Mitochondria are involved in salvage and nucleotide pool maintenance; imbalance can trigger innate immunity.
Conclusion
Pyrimidine nucleotide biosynthetic process (GO:0006221) is a central metabolic pathway that supplies the nucleotides required for DNA and RNA synthesis, cell proliferation, and mitochondrial function. Its dysregulation is implicated in cancer, viral infections, and innate immune activation, making it a rich area for therapeutic targeting. Model organisms and CRISPR-based tools continue to uncover the genetic and regulatory networks controlling this pathway. Understanding GO:0006221 provides a foundation for developing new treatments and advancing basic research in nucleotide metabolism.
References
- 1. Sprenger HG et al.. 2021. Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity.. Nat Metab 3(5):636-650 PMID: 33903774
- 3. Chandel NS. 2021. Nucleotide Metabolism.. Cold Spring Harb Perspect Biol 13(7) PMID: 34210662
- 4. Bodampati S et al.. 2024. Pyrimidine Nucleotide Biosynthesis and Regulation in Pseudomonas lemonnieri.. Curr Microbiol 82(1):3 PMID: 39576324
- 5. Domakonda A et al.. 2020. Control of pyrimidine nucleotide formation in Pseudomonas aurantiaca.. Arch Microbiol 202(6):1551-1557 PMID: 32125450
- 6. Okesli A et al.. 2017. Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.. Curr Opin Biotechnol 48:127-134 PMID: 28458037
- 7. Wang L. 2024. Zebrafish as a model for study of disorders in pyrimidine nucleotide metabolism.. Nucleosides Nucleotides Nucleic Acids 43(8):722-733 PMID: 38153103
- 8. Robinson AD et al.. 2020. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.. Cancer Lett 470:134-140 PMID: 31733288
